Bovine Gelatin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The bovine gelatin market size is expected to grow from USD 3.21 billion in 2025 to USD 3.55 billion in 2026, and is forecast to reach USD 4.32 billion by 2031, at a 6.14% CAGR over 2026-2031. This report is Segmented by Source (Hides, Bones, Tendons and Cartilage), Form (Powder and Liquid), Application (Food and Beverages, Pharmaceuticals, Cosmetics and Personal Care, Dietary Supplements, and Others), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Bovine Gelatin Market Trends and Insights

Sustained Growth Of Pharmaceutical Capsule Manufacturing

Pharmaceutical capsule production remains the clearest structural support for the bovine gelatin market because hard and soft capsules still sit at the center of oral solid dosage manufacturing in most major drug systems. The bovine gelatin market benefits from the fact that bovine gelatin remains widely accepted for capsule use when it meets documented quality, traceability, and treatment requirements across regulated supply chains. That support is not only about volume, because tighter quality expectations raise the value of each kilogram supplied for pharmaceutical use rather than simply increasing throughput. European import and treatment requirements for bovine inputs continue to favor certified producers that can maintain full documentation, which raises entry barriers for smaller spot-market suppliers. The result is that the bovine gelatin market gains from both expanding capsule output and a steady move toward more tightly specified pharmaceutical grades.

Expansion Of Nutraceutical And Healthy Aging Markets

The nutraceutical channel is giving the bovine gelatin market a broader demand base because collagen peptide products are being positioned for joint health, skin support, sports recovery, and active aging use. This is creating a split inside the bovine gelatin market between standard material sold for basic encapsulation and higher-value collagen and peptide ingredients sold with stronger health positioning. That shift matters because producers with the ability to separate premium grades from commodity output can protect pricing more effectively than suppliers focused only on bulk gelatin volumes. It also makes formulation quality, amino acid profile, and consistency more important in customer selection, especially in mature supplement markets where buyers are already familiar with collagen-based claims. As a result, the bovine gelatin market is moving beyond pure volume growth and is increasingly shaped by product mix and application quality, even where end-use demand appears similar on the surface.

Growing Popularity Of Plant-Based Alternatives

The strongest visible substitution pressure on the bovine gelatin market comes from plant-based capsule options such as HPMC and pullulan rather than from broad replacement across all gelatin uses. That pressure is concentrated in premium dietary supplements in North America and Europe, where vegan, vegetarian, and label-sensitive positioning has stronger commercial pull. The scale of investment around alternative capsule supply became clearer when Lone Star Funds agreed to acquire Lonza Group AG's Capsules and Health Ingredients division in March 2026. Even so, that pressure is not uniform because pharmaceutical, confectionery, and many emerging-market food applications still rely heavily on bovine gelatin for performance and cost reasons. The outcome is a more segmented bovine gelatin market where high-volume uses remain resilient but some premium growth moves toward plant-based encapsulation platforms.

Other drivers and restraints analyzed in the detailed report include:

• Strong Momentum In The Global Gummies Market
• Rapid Expansion Of Confectionery Consumption In Emerging Markets
• Volatility In Raw Material Availability And Pricing

Segment Analysis

Hides held 52.25% of the bovine gelatin market share by source in 2025, which reflects the long-standing link between tanning activity and gelatin extraction across established producing regions. The bovine gelatin market has depended on hides for decades because this raw material already sits inside well-developed collection and processing networks, which lowers procurement friction for large producers. Hide-derived gelatin remains especially relevant in uses that value clarity, familiar processing behavior, and wide industrial compatibility across capsule and dairy systems. That installed base hides a durable role even as the bovine gelatin industry becomes more selective about traceability and grade separation. Documentation requirements for treated bovine material in regulated export chains also strengthen the position of established producers that can prove origin, handling, and treatment history across the full chain. Those requirements do not eliminate smaller competitors, but they do make scale and compliance much more valuable in the source mix.

Bones are the fastest-growing source segment in the bovine gelatin market and are projected to expand at a 7.21% CAGR through 2031. That rise reflects the closer fit between bone-derived Type B gelatin and several pharmaceutical dissolution and pharmacopoeia requirements used in hard capsule systems. Research published in 2025 showed that papain-assisted enzymatic hydrolysis of bovine cattle bones preserved collagen chain structure more effectively than conventional acid or alkaline extraction routes. The same study found better Bloom strength, viscosity, and molecular weight distribution, which matters because those properties shape performance consistency in higher-spec uses. Bone growth also gives the bovine gelatin market a practical diversification benefit because bone availability tracks slaughter output more directly and is less tied to leather sector swings than hide availability. Over time, that reduces procurement imbalance and makes bones a more important strategic source rather than only a supplementary one, according to the MDPI research.

Complete Report Scope:

• Source
  • Hides
  • Bones
  • Tendons and Cartilage
• Form
  • Powder
  • Liquid
• Application
  • Food and Beverages
  • Pharmaceuticals
  • Cosmetics and Personal Care
  • Dietary Supplements
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Sweden
    • Poland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Vietnam
    • Indonesia
    • Thailand
    • Singapore
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Chile
    • Peru
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

Asia-Pacific held 30.28% of the bovine gelatin market in 2025, making it the largest regional base by share. China remains central to the bovine gelatin market because it combines large-scale processing, raw material access, and a deep manufacturing network that supports both domestic and export supply. India is also gaining importance because halal-certified pharmaceutical-grade output fits the needs of capsule buyers and regulated export channels, while Southeast Asian markets add demand from confectionery and healthcare manufacturing. Taken together, these conditions keep Asia-Pacific at the center of both supply scale and volume growth in the bovine gelatin market.

Europe is the fastest-growing region in the bovine gelatin market and is expected to post a 7.46% CAGR through 2031. That growth is being shaped more by quality upgrades and sourcing discipline than by simple volume expansion. Buyers in Europe operate under strict expectations around treatment, origin documentation, and traceability for bovine-derived material, which favors suppliers with audited chains and full compliance records. This raises the value of approved pharmaceutical and premium nutraceutical supply because customers are paying for assurance as much as for the ingredient itself. The result is a regional market where documented quality increasingly separates winners from undifferentiated commodity suppliers.

North America is a high-value demand center in the bovine gelatin market because of its deep pharmaceutical and dietary supplement manufacturing base. The United States remains especially important because capsule and supplement buyers there value specification control, documentation, and dependable supply history. The Middle East and Africa hold a smaller share, but they matter more each year as halal-certified imports support food, nutrition, and pharmaceutical expansion in Muslim-majority markets. Across both North America and the Middle East and Africa, market access depends heavily on suppliers that can align functional performance with recognized certification and traceability standards.

List of Companies Covered in this Report:

• Darling Ingredients Inc.
• GELITA AG
• Tessenderlo Group
• Nitta Gelatin Inc.
• Lapi Gelatine S.p.A.
• PB Leiner
• Rousselot
• Weishardt
• Trobas Gelatine B.V.
• India Gelatine and Chemicals Ltd.
• Narmada Gelatines Limited
• Nippi, Inc.
• Ewald Gelatine GmbH
• Gelken Gelatin Co., Ltd.
• Sterling Biotech Ltd.
• Junca Gelatines, S.L.
• Kenney and Ross Limited
• Gelnex
• ITALGEL S.p.A.
• Baotou Dongbao Bio-Tech Co., Ltd.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support